Anabiosis Medisciences Limited - Company Profile

It is a pharma public limited company based in Ahmedabad, Gujarat, India, established in 2004.
2004 Ahmedabad, Gujarat, India Active
Last Updated:
Access Report
About Anabiosis Medisciences Limited

Anabiosis Medisciences Limited, a active public limited company, was established on 24 June 2004 in Ahmedabad, Gujarat, India. Engaging in pharmaceutical retailers & distributors within the trade sector, it holds CIN: U24231GJ2004PLC044358. Registered under ROC Roc Ahmedabad. it is unlisted. It has an authorized capital of ₹1.05 Cr and a paid-up capital of ₹1.05 Cr.

It upholds a compliant status. Employing 27 professional, Its leadership includes Jyoti Jaiswal (Director), Siddharth Rajkumar Jaiswal (Director), Raj Kumar Jaiswal (Managing Director). Past directors included Anil Kumar Singh, Jyoti Jaiswal, Siddharth Rajkumar Jaiswal. It holds ₹1.68 Cr open charges and no settled loans. Its latest AGM occurred on 11 November 2023, with the balance sheet filed on 31 March 2023. It is based at 69, Greenpark Bunglows, Opp : City Gold Cinema, Nr. Ambali Gam, Uma Partyplot, Bopal, Ahmedabad, Gujarat, 380058.

Company Details
  • Email
    **********
  • Telephone

    +91-XXXXXXXXXX

  • Website
    **********
  • Social Media
    **********
  • Apps
    **********

Company Details

  • CIN/LLPIN

    U24231GJ2004PLC044358

  • Registration Number

    044358

  • Incorporation Date

    24 June 2004

  • Authorized Capital

    ₹1.05 Cr

  • Paid-Up Capital

    ₹1.05 Cr

  • ROC Code

    Roc Ahmedabad

  • Listing Status

    Unlisted

  • Company Status

    Active

Key Metrics
  • Authorised Capital ₹ 1.05 Cr
  • Paid Up Capital ₹ 1.05 Cr
  • Company Age 21 Year, 8 Months
  • Last Filing with ROC 31 Mar 2023
  • Open Charges ₹ 1.68 Cr
  • Revenue Growth **** -13.10%
  • Profit Growth **** -596.81%
  • Ebitda **** -105.44%
  • Net Worth 263.74%
  • Total Assets **** 27.12%
Company report

Anabiosis Medisciences Limited

Company Report FY 2025-2026

Comprehensive Company Insights

Explore comprehensive insights into Anabiosis Medisciences Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.

Access Report
Who are the key members and board of directors at Anabiosis Medisciences Limited?
Current Directors
Name Designation Appointment Date Status
Jyoti Jaiswal Director 18 Aug 2020 Current
Siddharth Rajkumar Jaiswal Director 18 Aug 2020 Current
Raj Kumar Jaiswal Managing Director 24 Jun 2004 Current
Past Directors
Name Designation Cessation Status
Pramod Abcsdd Director 24 Aug 2013 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past
Pramod Abcsdd Additional Director 30 Dec 2020 Past
Pramod Abcsdd Director 27 Nov 2009 Past
Pramod Abcsdd Director 18 Aug 2020 Past
Pramod Abcsdd Director 18 Aug 2020 Past

Discover detailed profiles of directors and KMP - Unlock leadership insights today!

Financial Performance of Anabiosis Medisciences.

Anabiosis Medisciences Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 13.1% decrease. The company also saw a substantial fall in profitability, with a 596.81% decrease in profit. The company's net worth Soared by an impressive increase of 263.74%.

Anabiosis Medisciences revenue growth over time
Anabiosis Medisciences profit and loss trends over time
Date Amount Transaction Name Valuation Lead Investors Investors
Jul, 2021 Amount Post-IPO - Grab Valuation

investors
Emtek
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
Jan, 2021 Amount Post-IPO - Grab Valuation

investors
Hana Financial Group , GGV Capital
Feb, 2021 Amount Post-IPO - Grab Valuation

investors
Signite Partners
  • Key Matrics
  • Balance Sheet
  • Profit and Loss
  • Cash Flow
  • Ratios
Metrics
(FY 2023) YOY Growth
(FY 2022) (FY 2021) (FY 2020) (FY 2019)
Total Revenue
********
 -13.10%
*******
*******
*******
*******
Revenue from Operations
*******
 -12.88%
*******
*******
*******
*******
Total Assets
*******
 27.12%
*******
*******
*******
*******
Profit or Loss
*******
 -596.81%
*******
*******
*******
*******
Net Worth
*******
 263.74%
*******
*******
*******
*******
EBITDA
*******
 -105.44%
*******
*******
*******
*******

Discover detailed financial data and - Unlock financial today!

What is the Ownership and Shareholding Structure of Anabiosis Medisciences?

In 2023, Anabiosis Medisciences had a promoter holding of 93.10% and a public holding of 6.90%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.

Shareholding Pattern (FY 2024)
shareholding
  • Promoters: 92.83%
  • Public: 4.10%
  • Others: 3.07%
Shareholding Pattern over the Year
FY (2024) FY (2023) FY (2022) FY (2021) FY (2020)
Promoters 92.83 94.62 94.55 94.55 94.55
Public 4.10 3.89 3.95 3.96 3.98
Others 3.07 1.49 1.50 1.49 1.47

Reveal ownership structures and financial performance - Get instant access now!

Charges (Loans)
Open Charges

₹16,800,000.00

Satisfied Charges

₹0

Charges Breakdown by Lending Institutions
  • Canara Bank : 1.68 Cr
Latest Charge Details
Date Lender Amount Status
10 May 2008 Canara Bank ₹1.68 Cr Open

Explore comprehensive loan charge details -

How Many Employees Work at Anabiosis Medisciences?

Anabiosis Medisciences has a workforce of 27 employees as of Feb 17, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.

Employee Date Number of Employees
2020 78,000
2021 80,500
2022 83,200
2023 86,000
2024 89,500
2025 92,000
Deals i
Graph showing company valuation over time

Gain comprehensive insights into the Deals and Valuation data of Anabiosis Medisciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Anabiosis Medisciences's trajectory.

Rating
Graph displaying rating trends over time

Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.

Alerts
Alert Indicator

Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.

Explore deal ratings and alerts - Get instant access now!

Latest Updates, News, and FAQs on Anabiosis Medisciences
Recent Activity within the Organization
  • Annual General Meeting

    Progress on Anabiosis Medisciences Limited last Annual general meeting of members was held on 11 Nov 2023 as per latest MCA records. was documented.

  • Charges

    Progress on A charge with Canara Bank of Rs. 1.68 Cr registered on 10 May 2008 with Charge ID 10145215 was modified on 01 May 2023. was documented.

  • Balance Sheet

    Anabiosis Medisciences Limited has filed its annual Financial statements for the year ended 31 Mar 2023 with Roc Ahmedabad. was recorded as a recent event.

  • Director Appointment

    Jyoti Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 7 months . was recorded as a recent event.

  • Director Appointment

    Progress on Siddharth Rajkumar Jaiswal was appointed as a Director was appointed as a Director on 18 Aug 2020 & has been associated with this company since 5 years 7 months . was documented.

  • Charges

    A charge with Canara Bank amounted to Rs. 1.68 Cr with Charge ID 10145215 was registered on 10 May 2008. was recorded as a recent event.

Explore recent activity and updates - View Recent Activity

Frequently Asked Questions
What is the CIN of Anabiosis Medisciences Limited?

The CIN of Anabiosis Medisciences Limited is U24231GJ2004PLC044358.

Where is Anabiosis Medisciences Limited headquartered?

Anabiosis Medisciences Limited is headquartered at 69, Greenpark Bunglows, Opp : City Gold Cinema, Nr. Ambali Gam, Uma Partyplot, Bopal, Ahmedabad, Gujarat, 380058.

When was Anabiosis Medisciences Limited incorporated?

Anabiosis Medisciences Limited was incorporated on 24 June 2004.

Who are the current directors of Anabiosis Medisciences Limited?

The current directors of Anabiosis Medisciences Limited are

What is the primary industry of Anabiosis Medisciences Limited?

The primary industry of Anabiosis Medisciences Limited is Trade.

Is Anabiosis Medisciences Limited a listed company?

Anabiosis Medisciences Limited is unlisted.

What is the capital structure of Anabiosis Medisciences Limited?

The authorized capital of Anabiosis Medisciences Limited is ₹1.05 Cr, and the paid-up capital is ₹1.05 Cr.

What is the compliance status of Anabiosis Medisciences Limited?

The compliance status of Anabiosis Medisciences Limited is Compliant.

Explore millions of companies — effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals — all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available